Method for the treatment of atopic eczema

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 35/20 (2006.01) A61K 38/17 (2006.01) A61K 38/18 (2006.01) A61K 38/30 (2006.01) A61K 38/38 (2006.01) A61K 38/40 (2006.01) A61P 17/00 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2687123

The present application relates to methods for the treatment of eczema and uses of a dairy-derived composition. The treatment involves oral administration of 800 mg/day of a composition comprising TGF-ß1, TGF-ß2, IGF-1 and 60% (w/w) beta-lactoglobulin derived from whey.

La présente invention concerne des procédés de traitement d'eczéma et les utilisations d'une composition dérivée de produits laitiers. Le traitement implique l'administration par voie orale de 800 mg/jour d'une composition comprenant tgf-ß1, tgf-ß2, igf-1 et bêta-lactoglobuline à 60 % (poids/poids) dérivée de petit-lait.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for the treatment of atopic eczema does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of atopic eczema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of atopic eczema will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1888380

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.